Companies / Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Nasdaq: COGTCIK 1622229WALTHAM, MA
Financials
Ownership
173.5M shares outstanding · as of Aug 6, 2026
Ownership
| 10%+ / strategic | 16.74% | 29,049,773 |
| Institutions | 85.52% | 148,395,211 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 3
View all →| Insider | % of shares | Shares |
|---|---|---|
Fairmount Funds Management LLCFormerDirector | 3.17% | 5,503,418 |
Ferrante Karen JeanDirector | — | — |
Morris ArleneDirector | — | — |
Institutional holders 288
View all →| Holder | Value | % of shares |
|---|---|---|
| $820.05M | 13.30% | |
| $671.55M | 10.00% | |
| $408.99M | 6.64% | |
| $348.10M | 5.21% | |
| $319.80M | 5.19% | |
| $269.68M | 4.38% | |
| $269.54M | 4.01% | |
| $229.63M | 3.44% | |
| $218.99M | 3.55% | |
| $208.44M | 3.38% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Fairmount Funds Management LLC Director | Sell | Common Stock | $242.62M | -7.0M -55.98% | 5,503,418 3.17% of shares | high |
| Jan 22, 2026 | Fairmount Funds Management LLC Director | Sell | Common Stock | $127.40M | -3.5M -38.87% | 5,503,418 3.17% of shares | high |
| Jun 9, 2026 | Morris Arlene Director | Grant | Stock Option (Right to Buy) | — | +18K | 17,901 0.01% of shares | low |
| Mar 31, 2026 | Fairmount Funds Management LLC Director | Other | Series A Convertible Preferred Stock | — | -28K -41.53% | 39,414 0.02% of shares | low |
| Mar 31, 2026 | Fairmount Funds Management LLC Director | Other | Common Stock | — | +7.0M +127.19% | 12,503,418 7.21% of shares | low |
| Jan 1, 2026 | Ferrante Karen Jean Director | Grant | Stock Option (Right to Buy) | — | +643 | 643 <0.01% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Vanguard Group Inc | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
| BlackRock, Inc. | Passive13G/A | — |
| Commodore Capital LP | Passive13G/A | — |
| Kynam Capital Management, LP | Passive13G/A | — |
| Deerfield Mgmt, L.P. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| COGT | — | 19240Q201 |